AEMD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States...

Stats
Today's Volume	1.06M
Average Volume	561 150
Market Cap	1.05M
EPS	$0 ( 2024-02-14 )
Next earnings date	( $-1.180 ) 2024-06-26
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0800
ATR14	$0.00200 (0.48%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-16	Broenniman Edward G	Buy	32 894	Common Stock
2024-04-16	Rossetti Angela	Buy	32 894	Common Stock
2024-04-16	Shah Chetan	Buy	32 894	Common Stock
2024-04-16	Gikakis Nicolas	Buy	32 894	Common Stock
2024-03-29	Gikakis Nicolas	Sell	1 954	Common Stock

INSIDER POWER
77.12
Last 96 transactions
Buy: 2 829 634 \| Sell: 209 502

Volume Correlation

Long: -0.25 (neutral)

Short: 0.96 (very strong)

Signal:(45.698) Expect same movement, but be aware

Aethlon Medical Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aethlon Medical Inc Correlation - Currency/Commodity

0.00
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.13
( neutral )

Aethlon Medical Inc Financials

Annual	2023
Revenue:	$574 245
Gross Profit:	$-4.44B (-773 707.70 %)
EPS:	$-69.72

FY	2023
Revenue:	$574 245
Gross Profit:	$-4.44B (-773 707.70 %)
EPS:	$-69.72

FY	2022
Revenue:	$294 165
Gross Profit:	$139 948 (47.57 %)
EPS:	$-7.06

FY	2021
Revenue:	$659 104
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.650

Financial Reports:

No articles found.

Aethlon Medical Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aethlon Medical Inc

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.